IBD-Associated Arthritis

Top Story

Less than 2% of infusions for pediatric rheumatic diseases result in adverse events

Less than 2% of infusions for pediatric rheumatic diseases result in adverse events
April 11, 2018

Samsung Bioepis, Abbvie settle lawsuit over Humira biosimilar

April 5, 2018
Samsung Bioepis and Abbvie have reached a global settlement agreement regarding the commercialization of SB5, the proposed adalimumab biosimilar for Humira, according to…
In the Journals

Younger age, high disease activity linked to methotrexate failure

April 4, 2018
Patients with arthritis who are younger, have rheumatoid factor positivity and demonstrate higher disease activity at baseline are at an increased risk for experiencing…

Sandoz obtains positive CHMP opinion for Remicade biosimilar

March 23, 2018
Sandoz received a positive opinion the European Medicines Agency’s Committee for Medicinal Products for Human Use for its proposed infliximab biosimilar for the…
More Headlines »
CME ABIM MOC

Ace the Case: A 56-year-old Caucasian Female with a 5-year History of Seropositive Rheumatoid Arthritis

There is no commercial support for this activity.

This “Ace the Case” study will discuss treatment options in patients with rheumatoid arthritis who have had an…
More »
Video
Meeting News

VIDEO: Speaker reviews factors that impact response to treatment for Crohn’s disease, ulcerative colitis

March 28, 2017
More »
Resource Centers
American College of Rheumatology Annual Meeting

American College of Rheumatology Annual Meeting

CME

Best of AWIR Immunology Bootcamp

This activity is supported by educational grants from AbbVie, Inc.; Lilly USA, LLC; and Sanofi Genzyme and Regeneron Pharmaceuticals.

Immune-mediated inflammatory disease (IMID) is a group of clinically heterogeneous disorders that share common…
More »